News | October 09, 2023
Mitsui invests in Lokavant Holdings
Lokavant provides clinical trial intelligence
Lokavant provides clinical trial intelligence
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
WINLEVI works differently from any other topical acne treatment
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Subscribe To Our Newsletter & Stay Updated
